The Point of Care Diagnostics Testing Market is characterized by a broad range of products, technologies, end users, and purchasing models. Market Research Future reports that the global market is projected to reach USD 157.87 billion by 2035 from USD 57.71 billion in 2024, registering a CAGR of 9.58%.

By product, the market covers glucose monitoring, cardiometabolic monitoring, infectious disease testing, coagulation monitoring, pregnancy and fertility testing, hematology testing, cancer and tumor marker testing, urinalysis, cholesterol testing, and drugs-of-abuse testing. Glucose monitoring currently represents a dominant product category because of the increasing prevalence of diabetes and the need for regular monitoring.

By end user, hospitals and clinics account for a major share, while diagnostic centers and homecare/self-testing represent additional segments. Home-based testing is gaining popularity because it offers convenience and faster access to diagnostic information.

The market is also segmented by platform into immunoassays, molecular diagnostics, and dipsticks. Immunoassays maintain a strong position, while molecular diagnostics are benefiting from technological advances.

Major companies participating in the industry include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Becton Dickinson and Company, Cepheid, Quidel Corporation, and Hologic.

Competitive differentiation is increasingly focused on technological innovation, diagnostic accuracy, product usability, and supply-chain capabilities.

Discover emerging opportunities with in-depth research reports:

Life Science Analytical Instruments Market Size

Lasik Eye Surgery Market Share

Lasik Eye Surgery Market Trends

Lasik Eye Surgery Market Growth

Lasik Eye Surgery Market Demand